Cancer has become such a prevalent phenomenon that it even has its own television show! It is the second most common leading cause of death, accounting for 7.6 million deaths in 2008 and projected to continue to an estimated 13.1 million deaths by 2030 2(WHO, 2013). But what does cancer actually entail?
On a basic molecular level it seems quite simple, a genetic mutation.
In normal tissue, the rate of cell division and the rate of cell loss are balanced to maintain. The rate of cell division is controlled by genes. Although, these genes may be activated in response to stimuli such as growth factors, which then promote cell division. In a similar fashion, cell division may be inhibited by repressor genes such as p53 gene (Martini & Nath, 2009). Other genes involved in normal embryonic development, to control cell turnover such as Ras is involved in cell-signalling pathways in the receptor tyrosine kinase pathway, and is also involved in the underlying mechanism of cancer; uncontrolled and excessive cell proliferation leading to enlarged tissue. However this cannot result in tumour formation by itself and requires mutation of p53 gene to result in tumour formation (Albertus, Johnson & Lewis, 2002).
The p53 gene is involved in cell-cycle control by preventing DNA replication of damaged cells. In addition to restricting cell division, this tumour suppressor gene allows cells to undergo apoptosis which is a normal physiological response that damaged cells may undertake as a protective measure to the body. Furthermore, p53 is involved in a mechanism that prohibits cell division to occur until its damaged DNA is repaired (Albertus et al., 2002).
Therefore, cell division may occur unchecked and cells may escape apoptosis thus spread to the rest of the body, moreover cells continue to proliferate with a corrupted genome. A consequence of these results in abnormalities in the chromosomes resulting in more DNA damage in successive cell divisions and widespread of havoc as depicted in figure 1. Therefore mutations of this p53 gene are critical in the persistence of cancer and unresponsiveness to treatment (Albertus et al., 2002).
However, as statistics and personal experiences of having loved ones who have battled and eventually succumbed to cancer, the effects of cancer are not simple at all. Cancer behaves as a parasite and competes with normal tissue for metabolic needs (Rippey, 1994). Sometimes, the tumours remain localised and are referred to as benign and may be removed although, it can displace adjacent tissue causing functional impairment of tissue and destruction. In malignant tumours, which are more invasive and rapidly growing they may infiltrate blood vessels reaching the blood stream and spread throughout the body (Underwood & Cross, 2009). Once cancer spreads it poses greater threat and makes treatment even more difficult.
Auto immune diseases
Auto immune diseases are similar to cancers in that they both represent a disturbed physiological function and have a genetic basis. However in auto immune disease it results from an auto immune response against a self- antigen which leads to tissue damage (Underwood & Cross, 2009).
As mentioned above, the cell-signalling pathways in the receptor tyrosine kinase pathway involved in cancer is also related to the regulation of the immune response. Tyrosine Kinase controls the JAK-STAT pathway which is hyper-activated in many auto immune diseases including rheumatoid arthritis and Crohn’s disease. In multiple sclerosis another kinase enzyme, Tyrosine Kinase 3 is involved in the maturation of dendritic cells which is disrupted in this disease (Sareum, 2013).
In conclusion, these modules focused upon the molecular occurrences at a more in-depth level as opposed to the level of detail covered in medical biosciences and medical microbiology. Cancer is definitely an important disease given that it is one of leading causes of mortality globally and considering the destruction inflicted upon the body as well as pain and emotional turmoil cancer patients undergo.
References
Martini, F.H. & Nath, J.L. (2009). Fundamentals of anatomy and physiology. USA: Pearson Benjamin Cummings
Rippey, J.J. (1994). General pathology. Johannesburg: Witswatersrand University Press.
Underwood, J.C.E. & Cross, S.S. (2009). General and systematic pathology. (5th ed.). China: Churchill-Livingstone.
Alberts, B., Johnson, A. and Lewis, J. (2002). Molecular Biology of the Cell. (4th ed.). New York: Garland Science. Retrieved, April 21, 2013 from:
http://www.ncbi.nlm.nih.gov/books/NBK26902/
Sareum. Drug Discovery – Cancer & Auto-Immune Disease Drug Programmes. Retrieved, April 21, 2013 from:
http://www.sareum.co.uk/cancer.php
WHO. Cancer. Retrieved, April 21, 2013 from:
http://www.who.int/mediacentre/factsheets/fs297/en/








